Should You Pick Johnson & Johnson Stock At $160?
Johnson & Johnson (NYSE: JNJ) reported its Q4 results last month, with revenues and earnings marginally above the street estimates.
Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson (NYSE: JNJ) reported its Q4 results last month, with revenues and earnings marginally above the street estimates.
Sittner & Nelson LLC trimmed its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 2.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,230 shares of the company’s stock after selling 420 shares during the quarter. Johnson & Johnson makes up […]
Tower Research Capital LLC TRC increased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 160.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 99,871 shares of the company’s stock after purchasing an additional 61,478 shares during the period. […]
Hi, it’s Kristen in New York. A reader has a question about Covid shot safety. But before we dive into that...
Select Asset Management & Trust increased its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 8.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,443 shares of the company’s stock after acquiring an additional 108 shares […]